Katherine Stueland - Mar 9, 2024 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Role: CHIEF EXECUTIVE OFFICER, Director
Signature: /s/ Devin Schaffer, Attorney-in-Fact
Stock symbol: WGS
Transactions as of: Mar 9, 2024
Transactions value $: $0
Form type: 4
Date filed: 3/12/2024, 05:26 PM
Previous filing: Dec 19, 2023
Next filing: Mar 13, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	WGS	Class A Common Stock	Options Exercise	$0	+6.55K	+12.45%	$0.00	59.1K	Mar 9, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	WGS	Restricted Stock Unit	Options Exercise	$0	-6.55K	-8.33%	$0.00	72K	Mar 9, 2024	Class A Common Stock	6.55K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
F2	6.25% vest in quarterly installments over the 4-year period commencing on March 9, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.